UNION CITY, Calif.,
Jan. 5, 2016 /PRNewswire/ -- Abaxis,
Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing
point-of-care instruments and consumables for the medical,
research, and veterinary markets worldwide, announced today that
Clint Severson, Chairman and Chief
Executive Officer, will present at the 34th Annual J.P.
Morgan Healthcare Conference on Thursday,
January 14, 2016 at 11:00 a.m.
PT in San Francisco,
California.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer
of portable blood analysis systems that are used in a broad range
of medical specialties in human or veterinary patient care to
provide clinicians with rapid blood constituent measurements.
Our mission is to improve the efficiency of care delivery to and
the quality of life of patients in the medical and veterinary
markets. We provide leading edge technology, tools and
services that support best medical practices, enabling physicians
and veterinarians to respond to the health needs of their clients
at the point of care while operating economical and profitable
practices. For more information, visit
http://www.abaxis.com.
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
ABAXIS,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/abaxis-inc-to-present-at-the-34th-annual-jp-morgan-healthcare-conference-300199291.html
SOURCE Abaxis, Inc.